An organic light-emitting device including a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer, wherein the organic layer includes a compound represented by Formula 1:

##STR00001##

When the compound represented by Formula 1 is used as electron-transporting material, an organic light-emitting device including this compound may show significantly improved efficiency, driving voltage, high luminance, and long lifespan characteristics.

An organic light-emitting device including a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer, wherein the organic layer includes a compound represented by Formula 1:

##STR00001##

When the compound represented by Formula 1 is used as electron-transporting material, an organic light-emitting device including this compound may show significantly improved efficiency, driving voltage, high luminance, and long lifespan characteristics.

The present invention relates to diaminophenothiazinium derivatives of formula (I); in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and X.sup. are as defined in Claim 1, and also the methods for labelling oligonucleotides using such a derivative, labeling substrates and the oligonucleotides which can be obtained by means of such methods or from such labelling substrates.

The present invention relates to diaminophenothiazinium derivatives of formula (I); in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and X.sup. are as defined in Claim 1, and also the methods for labelling oligonucleotides using such a derivative, labeling substrates and the oligonucleotides which can be obtained by means of such methods or from such labelling substrates.

The present invention provides benzothiadiazine and chroman derivatives and particularly diazoxide and cromakalim derivatives for use in treating glaucoma, retinopathy, treating age related macular degeneration, treating, stabilizing and/or inhibiting blood and lymph vascularization, and reducing intraocular pressure by administering a pharmaceutically effective amount of a prodrug disposed in an ophthalmically acceptable carrier to the eye, wherein the prodrug specifically modulates a KATP channel to reduce an intraocular pressure.

The present invention provides benzothiadiazine and chroman derivatives and particularly diazoxide and cromakalim derivatives for use in treating glaucoma, retinopathy, treating age related macular degeneration, treating, stabilizing and/or inhibiting blood and lymph vascularization, and reducing intraocular pressure by administering a pharmaceutically effective amount of a prodrug disposed in an ophthalmically acceptable carrier to the eye, wherein the prodrug specifically modulates a KATP channel to reduce an intraocular pressure.

The present invention discloses a conductive substrate, a perovskite substrate using the conductive substrate, and a solar cell using the perovskite substrate. The conductive substrate, the perovskite substrate, and the solar cell of the present invention include a conductive base and a conductive compound stacked on the conductive base. The conductive compound is represented by Formula 1, 2 or 3. The conductive compound is capable of multi-electron redox reactions, possesses p-type organic molecular properties, and has an oxidation potential or highest occupied molecular orbital (HOMO) matching the valence band of perovskite so that holes generated in an absorber layer are selectively separated for the application of the perovskite material, achieving enhanced photoelectric conversion efficiency of the solar cell and a significantly reduced difference between the forward and reverse conversion efficiencies (hysteresis index) of the solar cell.

The present invention discloses a conductive substrate, a perovskite substrate using the conductive substrate, and a solar cell using the perovskite substrate. The conductive substrate, the perovskite substrate, and the solar cell of the present invention include a conductive base and a conductive compound stacked on the conductive base. The conductive compound is represented by Formula 1, 2 or 3. The conductive compound is capable of multi-electron redox reactions, possesses p-type organic molecular properties, and has an oxidation potential or highest occupied molecular orbital (HOMO) matching the valence band of perovskite so that holes generated in an absorber layer are selectively separated for the application of the perovskite material, achieving enhanced photoelectric conversion efficiency of the solar cell and a significantly reduced difference between the forward and reverse conversion efficiencies (hysteresis index) of the solar cell.